MetLife (NYSE:MET) Announces Earnings Results

MetLife (NYSE:MET) issued its earnings results on Wednesday. The financial services provider reported $2.58 EPS for the quarter, topping the consensus estimate of $2.34 by $0.24, Zacks reports. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $31.43 billion. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The business’s revenue was up 27.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.08 EPS.

MetLife Price Performance

MetLife stock traded down $1.25 during trading hours on Thursday, hitting $76.76. 3,097,069 shares of the company traded hands, compared to its average volume of 3,658,130. MetLife has a 1-year low of $65.21 and a 1-year high of $87.39. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of 0.54. The firm has a market cap of $50.57 billion, a P/E ratio of 14.43, a P/E/G ratio of 0.73 and a beta of 0.77. The firm’s 50-day simple moving average is $78.92 and its two-hundred day simple moving average is $78.84.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be paid a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a yield of 3.0%. MetLife’s dividend payout ratio (DPR) is presently 42.75%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. UBS Group boosted their target price on shares of MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a research note on Thursday. Barclays set a $90.00 price objective on shares of MetLife in a research report on Thursday, January 8th. Weiss Ratings reiterated a “buy (b-)” rating on shares of MetLife in a research note on Monday, December 29th. Morgan Stanley set a $101.00 target price on MetLife and gave the company an “overweight” rating in a research note on Monday, December 15th. Finally, Mizuho set a $102.00 target price on MetLife in a report on Wednesday, January 14th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $95.64.

Institutional Trading of MetLife

A number of hedge funds and other institutional investors have recently modified their holdings of MET. Sivia Capital Partners LLC bought a new stake in shares of MetLife during the 2nd quarter worth $404,000. Brighton Jones LLC boosted its holdings in shares of MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock worth $347,000 after buying an additional 351 shares during the period. Polymer Capital Management HK LTD purchased a new stake in shares of MetLife in the 3rd quarter valued at approximately $224,000. Polymer Capital Management US LLC grew its position in MetLife by 11.4% during the 3rd quarter. Polymer Capital Management US LLC now owns 2,858 shares of the financial services provider’s stock worth $235,000 after purchasing an additional 293 shares in the last quarter. Finally, Clark Capital Management Group Inc. grew its position in MetLife by 4.8% during the 3rd quarter. Clark Capital Management Group Inc. now owns 3,175 shares of the financial services provider’s stock worth $262,000 after purchasing an additional 145 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Adjusted earnings and investment returns surprised to the upside—company disclosures and several outlets highlighted stronger adjusted EPS and that investment performance materially lifted timing‑adjusted profit measures, supporting the stock’s rally. Read More.
• Positive Sentiment: Management framed results as “strong 2025 results and growth momentum,” and released a CFO update video and slide deck that emphasize adjusted earnings growth and higher PFOs (premiums, fees & other revenues), which reassures investors focused on underlying operating performance. Read More.
• Neutral Sentiment: Business mix: group benefits and Retail & Institutional Solutions (RIS) were highlighted as contributors to quarter strength — a favorable signal for recurring revenue, but not necessarily immediate margin upside across the whole company. Read More.
• Neutral Sentiment: Regional growth angle — analysts noted Asia remains a potential offset to credit and macro headwinds; that’s a medium‑term tailwind but not an immediate cure for quarter‑to‑quarter volatility. Read More.
• Negative Sentiment: Revenue and GAAP metrics were mixed versus some Street measures — several reports flagged revenue came in below certain consensus references and GAAP EPS/earnings measures diverged from adjusted figures, which raises short‑term uncertainty about reported profitability. Read More.
• Negative Sentiment: Headline revenue miss coverage — media outlets called out that revenue missed some estimates, which likely pressured cautious investors despite the adjusted‑EPS beat. Expect debate between those focusing on adjusted metrics vs GAAP results to drive intra‑day volatility. Read More.
• Neutral Sentiment: Context & positioning: analysts’ price targets remain generally above current levels and several large institutions have been adding to positions — this supports a constructive medium‑term view even as near‑term numbers spark debate. Read More.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.